D
Nurix Therapeutics, Inc. NRIX
$13.59 $0.403.03%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

11/30/2024 08/31/2024 05/31/2024 02/29/2024 11/30/2023
Revenue -12.37% -31.84% -60.58% 30.74% 123.49%
Total Other Revenue -- -- -- -- --
Total Revenue -12.37% -31.84% -60.58% 30.74% 123.49%
Cost of Revenue 35.22% 15.93% 6.90% 9.14% 7.82%
Gross Profit -56.10% -45.95% -144.12% -0.87% 12.13%
SG&A Expenses -0.58% 10.31% 0.27% 20.14% 15.08%
Depreciation & Amortization -- -- -- -- --
Other Operating Expenses -- -- -- -- --
Total Operating Expenses 28.84% 14.91% 5.56% 11.08% 9.05%
Operating Income -42.62% -36.49% -81.36% -5.28% 6.89%
Income Before Tax -39.53% -32.16% -83.12% -1.71% 10.19%
Income Tax Expenses -- -- -- -- --
Earnings from Continuing Operations -39.55% -32.38% -83.49% -1.93% 10.19%
Earnings from Discontinued Operations -- -- -- -- --
Extraordinary Item & Accounting Change -- -- -- -- --
Minority Interest in Earnings -- -- -- -- --
Net Income -39.55% -32.38% -83.49% -1.93% 10.19%
EBIT -42.62% -36.49% -81.36% -5.28% 6.89%
EBITDA -41.54% -37.19% -85.81% -4.79% 7.19%
EPS Basic 2.70% 1.06% -59.61% -0.31% 11.39%
Normalized Basic EPS 2.71% 1.25% -59.30% -0.08% 11.40%
EPS Diluted 2.70% 1.06% -59.61% -0.31% 11.39%
Normalized Diluted EPS 2.71% 1.25% -59.30% -0.08% 11.40%
Average Basic Shares Outstanding 43.42% 33.81% 14.96% 1.62% 1.35%
Average Diluted Shares Outstanding 43.42% 33.81% 14.96% 1.62% 1.35%
Dividend Per Share -- -- -- -- --
Payout Ratio -- -- -- -- --
Weiss Ratings